Compare Adaptive Biotechnologies Corp (ADPT) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Pinterest Inc — how do they compare? Adaptive Biotechnologies Corp trades at $24.99 (market cap $4.04B), while Pinterest Inc trades at $22.96 (market cap $13.45B). The key difference: Pinterest Inc is far larger — about 3.3× Adaptive Biotechnologies Corp's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals.
| ADPT | PINS | |
|---|---|---|
Market Cap | $4.04B | $13.45B |
Sector | Health | Media |
52-Week High | $25.45 | $37.95 |
52-Week Low | $12.30 | $15.42 |
Enterprise Value | $4.10B | $13.37B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADPT trades at $24.94, down 2.0% today but near its 52-week high. The stock shows a bullish technical trend with improving fundamentals, including 49% MRD revenue growth and narrowing losses. A recent 4:1 reverse stock split and planned business separation aim to unlock value, with analyst consensus leaning bullish.
Outlook is cautiously optimistic due to strong revenue growth and margin expansion, but risks persist from ongoing net losses and competitive pressures. The stock offers potential upside to the $25.50 consensus target if execution continues improving, yet volatility may remain until profitability is achieved.
Pinterest (PINS) trades at $22.90, down 6.03% over 24 hours, with a bullish technical signal from moving averages but neutral oscillators. The company reported Q2 2026 EPS of $0.43, beating estimates of $0.36, driven by 18% revenue growth and record monthly active users. However, the stock faces pressure from lukewarm Q3 revenue guidance and competitive ad market concerns.
The outlook remains positive with strong analyst support—54% recommend Buy—and a $28.69 consensus price target implying 25% upside. Key risks include intense advertising competition and potential growth deceleration, but fundamentals are solid with revenue climbing to $4.22B in 2025 and a robust 79.47% gross margin.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
